AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, Dec 27 Asia Pulse - Indian pharmaceutical firm Suven Life Sciences (BSE:530239) yesterday said the US Patent office has granted it a product patent for compounds used in the treatment of neuro-degenerative disorders.
"We are very pleased by the issuance of this patent to Suven by US Patent office for our drug candidates that are being developed for CNS disorders which targets a US$18-billion potential market opportunity," said Venkat Jasti, CEO of Suven Life Sciences.
Suven has been granted product patent 'US 7,297,711', its first product patent in the United States, the company said in a filing to the Bombay Stock Exchange.
According to the…
Source: HighBeam Research, INDIA'S SUVEN GETS US PATENT OFFICE NOD FOR NEURO DRUG.